Larvol Delta - Galecto-Completes-Strategic-Review-to-Focus-on-Oncology-and-Liver-Disease-and-Acquires-Acute-Myeloid-Leukemia-Preclinical-Asset-from-Bridge-Medicines

GB1211 - Galecto

lenumlostat (GB2064) - Galecto

BRM-1420 - Galecto

https://www.globenewswire.com/news-release/2024/10/07/2958933/0/en/Galecto-Completes-Strategic-Review-to-Focus-on-Oncology-and-Liver-Disease-and-Acquires-Acute-Myeloid-Leukemia-Preclinical-Asset-from-Bridge-Medicines.html

Oct 7, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev